Literature DB >> 17484629

Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na(+),K(+))- and Mg(2+)-ATPase activities in offspring rats.

Charis Liapi1, Irini Feskou, Apostolos Zarros, Panagiota Galanopoulou, Stylianos Tsakiris.   

Abstract

BACKGROUND: Choline plays an important role in brain development. Choline-deficient diet (CDD) is known to produce (among other effects) a decrease in acetylcholine in rat brains. The aim of our study was to investigate how CDD administration during gestation and lactation could affect total antioxidant status (TAS) and activities of acetylcholinesterase (AChE), (Na(+),K(+))- and Mg(2+)-ATPase in the brains of both male and female newborn and suckling (21-day-old) rats.
METHODS: Three different experiments were performed. Whole brains were obtained from: (a) newborn rats following gestational CDD (experiment I); (b) 21-day-old rats following gestational but not lactational CDD (experiment II); and (c) 21-day-old rats following gestational and lactational CDD (experiment III). Enzyme activities and TAS were measured spectrophotometrically.
RESULTS: In choline-deprived (CD) newborn rats, TAS and AChE and Na(+),K(+)-ATPase activities were significantly reduced by 23%, 24% and 50%, respectively, in the brains of both sexes. Gestational CDD caused only a decrease in TAS (-27%, p<0.001) in suckling rat brains in both sexes. No changes were observed for the other enzyme activities. Moreover, gestational and lactational CDD also led only to a decrease in TAS (-24%, p<0.001) in the suckling rat brains of both sexes. Mg(2+)-ATPase activities showed no changes after any of the experimental procedures.
CONCLUSIONS: Our data suggest that the lower enzyme activities in newborn CD brains were restored to normal after 21 days of either normal or CDD lactation, possibly due to novel synaptogenesis, endogenous neuroregulation, and/or to other substances acquired by lactation. The increase in homocysteine concentration due to choline deficiency reported in the literature may be the cause of the low antioxidant capacity observed in offspring rat brains. Brain Na(+),K(+)-ATPase inhibition (induced by CDD) could result in modulations of neural excitability, metabolic energy production and neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484629     DOI: 10.1515/CCLM.2007.118

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

1.  Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy.

Authors:  Charis Liapi; Argyro Kyriakaki; Apostolos Zarros; Panagiota Galanopoulou; Hussam Al-Humadi; Ismene Dontas; Konstantinos Voumvourakis; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2010-09-14       Impact factor: 3.584

2.  Exposure to ethanol during neurodevelopment modifies crucial offspring rat brain enzyme activities in a region-specific manner.

Authors:  Vasileios Stolakis; Charis Liapi; Apostolos Zarros; Konstantina Kalopita; Vassilios Memtsas; John Botis; Anastasia Tsagianni; Despoina Kimpizi; Alexios Varatsos; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2015-09-17       Impact factor: 3.584

3.  Combined thirty-day exposure to thioacetamide and choline-deprivation alters serum antioxidant status and crucial brain enzyme activities in adult rats.

Authors:  Charis Liapi; Hussam Al-Humadi; Apostolos Zarros; Panagiota Galanopoulou; Vasileios Stolakis; Elena Gkrouzman; Zois Mellios; Nikolina Skandali; Foteini Anifantaki; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2009-08-21       Impact factor: 3.584

4.  Equilibrated diet restores the effects of early age choline-deficient feeding on rat brain antioxidant status and enzyme activities: the role of homocysteine, L-phenylalanine and L-alanine.

Authors:  Charis Liapi; Irini Feskou; Apostolos Zarros; Haris Carageorgiou; Panagiota Galanopoulou; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2008-07-19       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.